BioSpace News Archive

3D InSight™ Human Liver Disease platform provides the most physiologically relevant testing environment for efficacy and safety

This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform.

The global isoflavones market is expected to post a CAGR close to 15% during the period 2019-2023, according to the latest market research report by Technavio.

According to Coherent Market Insights, the global single use disposable patient positioning products market was valued at US$ 127.7 million in 2018, and is projected to exhibit a CAGR of 3.5% during the forecast period (2018 – 2026).

Millennium Health, a leader in identifying and responding to illicit and prescription drug use trends, has expanded its urine drug test offering to include fentanyl analogues

OrthogenRx®, Inc., a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA) has announced that their CEO, Dr. Michael Daley, was awarded the 2019 Entrepreneur of the Year Award by the Pennsylvania Biotechnology Center (PABC) of Bucks County in Doylestown, PA

This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US.

St. Jude Children’s Research Hospital® and ALSAC, the fundraising and awareness organization for St. Jude, announced new leadership to the ALSAC Board of Directors and St. Jude Board of Governors.

The announcement signals accelerated access to more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago.

The program helps school nurses stay up-to-date on changes in the rapidly evolving field of health care, empowering them to more effectively care for students in their charge.